VI

Vicore Pharma Holding ABSTO Vicore Pharma Stock Report

Last reporting period 30 Jun, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.155

Micro

Exchange

XSTO - Nasdaq STOCKHOLM AB

View Full Company Analysis

Vicore Cash and equivalents

0.47 B

Last period Cash and equivalents ,SEK

141%

Cash and equivalents has increased in 5 years


What is Cash and equivalents ?

Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.

What is Cash and equivalents ?

Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.

What is Cash and equivalents of Vicore Pharma ?

Vicore Pharma`s Cash and equivalents for the period ended 2024-06-30 are 0.47 B SEK

View Full Company Analysis